• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DIASORIN S.P.A. LIAISON SARS-COV-2 S1/S2 IGG; QUALITATIVE DETECTION OF IGG ANTIBODIES TO SARS-COV-2

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DIASORIN S.P.A. LIAISON SARS-COV-2 S1/S2 IGG; QUALITATIVE DETECTION OF IGG ANTIBODIES TO SARS-COV-2 Back to Search Results
Catalog Number 311460
Device Problem False Positive Result (1227)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Manufacturer Narrative
Diasorin (b)(4) received a complaint from a customer stating that device's suspected false positive reactivity was detected as part of a scientific study.Single mdr related to each involved batch is submitted: lot 258005 mdr code 9610240-2021-00022; lot 258007; lot 258008 mdr code 9610240-2021-00024; diasorin (b)(4) received a complaint from a customer stating that discrepancies were detected comparing diasorin liaison sars-cov-2 s1/s2 igg results with abbott architect results.Based on data analysis, positive and negative controls were found only twice out of the manufacturer's ranges.Customer repeated testing of discordant samples and all index values were lower.Four of the samples, initially resulted positive, resulted as negative upon re-testing.Variation may be generally expected when a test is detecting antibodies, since different antibodies families are present depending on the patient and can be detected in different ways by different antigens and/or methods.In addition, differences between methods might be observed because of different kind of solid phase, different antigen preparation and concentration origins.Complaint was classified as not confirmable.As reported on ifu, the liaison sars-cov-2 s1/s2 igg assay and its clinical performance were based on clinical sensitivity defined by pcr positive; no comparison studies with other serological tests are available.Differences with competitor tests may be expected and cannot be related to product deficiencies.
 
Event Description
In light of the covid-19 pandemic and the subsequent authorizations (euas) for sars-cov-2 diagnostics tests and per the conditions of the emergency use authorization, suspected false negatives, false positives and significant changes in expected performance characteristics will be reported under 21 cfr 803.The alleged false test results in this event have not caused patient injury or death; however, this event is being reported conservatively because if the alleged malfunction were to recur there is a non-remote potential for serious injury or death.Diasorin (b)(4) received a complaint from a customer stating that discrepancies were detected comparing diasorin liaison sars-cov-2 s1/s2 igg results with abbott architect results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIAISON SARS-COV-2 S1/S2 IGG
Type of Device
QUALITATIVE DETECTION OF IGG ANTIBODIES TO SARS-COV-2
Manufacturer (Section D)
DIASORIN S.P.A.
via crescentino snc
saluggia, vercelli 13040
IT  13040
Manufacturer (Section G)
DIASORIN S.P.A.
via crescentino snc
saluggia, vercelli 13040
IT   13040
Manufacturer Contact
barbara belluati
via crescentino snc
saluggia, vercelli 13040
IT   13040
MDR Report Key11988954
MDR Text Key259192156
Report Number9610240-2021-00023
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/13/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/24/2020
Device Catalogue Number311460
Device Lot Number358007
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/28/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/07/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-